| Solifenacin |
20140387 |
Solifenacin Accord, Film coated tablet, 5, mg, Pack: 30 |
Accord Healthcare Polska Sp. z.o.o., Полша |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft., Унгария; Pharmacare Premium Ltd., Малта |
27.11 |
5.42 |
32.53 |
6% |
1.63 |
28.74 |
5.75 |
34.49 |
18% |
4.88 |
33.62 |
6.72 |
40.34 |
Промяна на обстоятелства НСР-19707/29.08.2019 |
НСР-8455/07.03.2016; НСР-15729/25.05.2018 |
09.06.2018 |
02.10.2019 |
Активен |
4202 |
| Solifenacin |
20140387 |
Solifenacin Accord, Film coated tablet, 5, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft., Унгария; Pharmacare Premium Ltd., Малта |
27.11 |
5.42 |
32.53 |
6% |
1.63 |
28.74 |
5.75 |
34.49 |
18% |
4.88 |
33.62 |
6.72 |
40.34 |
|
НСР-8455/07.03.2016; НСР-15729/25.05.2018 |
09.06.2018 |
02.07.2018 |
Неактивен |
4202 |
| Solifenacin |
20140387 |
Solifenacin Accord, Film coated tablet, 5, mg, Pack: 30 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft., Унгария; Pharmacare Premium Ltd., Малта |
27.38 |
5.48 |
32.86 |
6% |
1.64 |
29.02 |
5.8 |
34.82 |
18% |
4.93 |
33.95 |
6.79 |
40.74 |
|
НСР-8455/07.03.2016 |
22.03.2016 |
22.03.2016 |
Неактивен |
4202 |
| Solifenacin |
20150064 |
Solifenacin Medica, Film coated tablet, 5, mg, Pack: 30 |
Медика АД, България |
Медика АД, Сандански, България |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
|
НСР-8454/07.03.2016 |
22.03.2016 |
22.03.2016 |
Неактивен |
4201 |
| Solifenacin |
20120213 |
Solifenacin Sandoz, Film coated tablet, 5, mg, Pack: 30 |
Sandoz d.d., Словения |
S.C. Zentiva S.A., Румъния; Lek Pharmaceuticals d.d., Словения |
17 |
3.4 |
20.4 |
6% |
1.02 |
18.02 |
3.6 |
21.62 |
18% |
3.06 |
21.08 |
4.22 |
25.3 |
промяна на обстоятелства НСР-14204/19.10.2017; НСР-16942/04.10.2018 |
НСР-5165/27.11.2014; НСР-15111/26.02.2018 предварително изпълнение; НСР-17002/12.10.2018 |
02.11.2018 |
02.11.2018 |
Заличен |
3405 |
| Solifenacin |
20120213 |
Solifenacin Sandoz, Film coated tablet, 5, mg, Pack: 30 |
Sandoz d.d., Словения |
Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения |
17 |
3.4 |
20.4 |
6% |
1.02 |
18.02 |
3.6 |
21.62 |
18% |
3.06 |
21.08 |
4.22 |
25.3 |
промяна на обстоятелства НСР-14204/19.10.2017 |
НСР-5165/27.11.2014; НСР-15111/26.02.2018 предварително изпълнение |
26.02.2018 |
02.03.2018 |
Неактивен |
3405 |
| Solifenacin |
20120213 |
Solifenacin Sandoz, Film coated tablet, 5, mg, Pack: 30 |
Sandoz d.d., Словения |
Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения |
27.11 |
5.42 |
32.53 |
6% |
1.63 |
28.74 |
5.75 |
34.49 |
18% |
4.88 |
33.62 |
6.72 |
40.34 |
промяна на обстоятелства НСР-14204/19.10.2017 |
НСР-5165/27.11.2014 |
11.12.2014 |
02.12.2017 |
Неактивен |
3405 |
| Solifenacin |
20150064 |
Solifenacin SOPHARMA, Film coated tablet, 5, mg, Pack: 30 |
Софарма АД, България |
Софарма АД, Индустриална зона, 2800 Сандански, България |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Промяна на обстоятелства НСР-14771/22.12.2017 |
НСР-8454/07.03.2016 |
22.03.2016 |
02.02.2018 |
Активен |
4201 |
| Solifenacin |
20190039 |
Solifenacon, Film coated tablet, 5, mg, Pack: 30 |
Фармаконс АД, България |
Фармаконс АД, България |
20.57 |
4.11 |
24.68 |
6% |
1.23 |
21.8 |
4.36 |
26.16 |
18% |
3.7 |
25.5 |
5.1 |
30.6 |
|
НСР-18930/13.06.2019г. |
28.06.2019 |
02.07.2019 |
Активен |
16572 |
| Methylprednisolone |
II-9510/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 250, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
6.1 |
1.22 |
7.32 |
7% |
0.43 |
6.53 |
1.31 |
7.84 |
20% |
1.22 |
7.75 |
1.55 |
9.3 |
Цената се заличава с решение НСР-5879/27.03.2015 |
НСР-3598/23.05.2014 |
06.06.2014 |
06.06.2014 |
Заличен |
2835 |
| Methylprednisolone |
II-9511/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 40, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
1.86 |
0.37 |
2.23 |
7% |
0.13 |
1.99 |
0.4 |
2.39 |
20% |
0.37 |
2.36 |
0.47 |
2.83 |
Цената се заличава с решение НСР-5879/27.03.2015 |
НСР-2339/13.01.2014 |
28.01.2014 |
28.01.2014 |
Заличен |
2398 |
| Methylprednisolone |
II-9512/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 500, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
7.76 |
1.55 |
9.31 |
7% |
0.54 |
8.3 |
1.66 |
9.96 |
20% |
1.55 |
9.85 |
1.97 |
11.82 |
Цената се заличава с решение НСР-5879/27.03.2015 |
КЦ-3173/04.11.2011 |
06.03.2013 |
06.03.2013 |
Заличен |
1640 |
| Methylprednisolone |
II-9509/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 125, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
3.19 |
0.64 |
3.83 |
7% |
0.22 |
3.41 |
0.68 |
4.09 |
20% |
0.64 |
4.05 |
0.81 |
4.86 |
Цената се заличава с решение НСР-3242/14.04.2014 |
КЦ-3173/04.11.2011 |
06.03.2013 |
06.03.2013 |
Заличен |
1639 |
| Methylprednisolone |
II-9511/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 40, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
2.21 |
0.44 |
2.65 |
7% |
0.15 |
2.36 |
0.47 |
2.83 |
20% |
0.44 |
2.8 |
0.56 |
3.36 |
|
КЦ-3173/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2398 |
| Methylprednisolone |
II-9512/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 500, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
9.72 |
1.94 |
11.66 |
7% |
0.68 |
10.4 |
2.08 |
12.48 |
20% |
1.94 |
12.34 |
2.47 |
14.81 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
1640 |
| Methylprednisolone |
II-9511/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 40, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
2.29 |
0.46 |
2.75 |
7% |
0.16 |
2.45 |
0.49 |
2.94 |
20% |
0.46 |
2.91 |
0.58 |
3.49 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2398 |
| Methylprednisolone |
II-9510/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 250, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
6.14 |
1.23 |
7.37 |
7% |
0.43 |
6.57 |
1.31 |
7.88 |
20% |
1.23 |
7.8 |
1.56 |
9.36 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2835 |
| Methylprednisolone |
II-9509/10.08.2004 |
SOLU-MEDROL, Powder and solvent for solution for injection, 125, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium |
3.29 |
0.66 |
3.95 |
7% |
0.23 |
3.52 |
0.7 |
4.22 |
20% |
0.66 |
4.18 |
0.84 |
5.02 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
1639 |
| Somatostatin |
II-14278/27.09.2006 |
SOMATOSTATIN LYOMARK, Powder for solution for injection/infusion, 3, mg, Pack: 5 |
Lyomark Pharma GmbH, Германия |
Wasserburger Arzneimittelwerk GmbH, Germany |
567.19 |
113.44 |
680.63 |
4% |
10 |
577.19 |
115.44 |
692.63 |
16% |
25 |
602.19 |
120.44 |
722.63 |
Протокол №242/14.09.2017 |
КЦ-1152/07.10.2009 |
29.10.2009 |
02.10.2017 |
Активен |
832 |
| Somatostatin |
II-14278/27.09.2006 |
SOMATOSTATIN LYOMARK, Powder and solvent for solution for injection, 3, mg, Pack: 1 |
Lyomark Pharma GmbH, Германия |
Wasserburger Arzneimittelwerk GmbH, Germany |
131.04 |
26.21 |
157.25 |
4% |
5.24 |
136.28 |
27.26 |
163.54 |
16% |
20.97 |
157.25 |
31.45 |
188.7 |
Прот. № 217/30.03.2017 |
КЦ-1152/07.10.2009 |
29.10.2009 |
02.04.2017 |
Активен |
831 |
| Somatostatin |
II-14278/27.09.2006 |
SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 5 |
Lyomark Pharma GmbH, Германия |
Wasserburger Arzneimittelwerk GmbH, Germany |
567.19 |
113.44 |
680.63 |
4% |
10 |
577.19 |
115.44 |
692.63 |
16% |
25 |
602.19 |
120.44 |
722.63 |
|
КЦ-1152/07.10.2009 |
29.10.2009 |
29.10.2009 |
Неактивен |
832 |
| Somatostatin |
II-14278/27.09.2006 |
SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 1 |
Lyomark Pharma GmbH, Германия |
Wasserburger Arzneimittelwerk GmbH, Germany |
131.04 |
26.21 |
157.25 |
4% |
5.24 |
136.28 |
27.26 |
163.54 |
16% |
20.97 |
157.25 |
31.45 |
188.7 |
|
КЦ-1152/07.10.2009 |
29.10.2009 |
29.10.2009 |
Неактивен |
831 |
| Somatostatin |
20120385 |
Somatostatin PH&T, Powder and solvent for solution for injection, 3, mg, Pack: 1 флакон + 1 ампула |
PH & T S.p.A., Италия |
Alfa Wassermann S.p.A., Италия |
93.96 |
18.79 |
112.75 |
4% |
3.76 |
97.72 |
19.54 |
117.26 |
16% |
15.03 |
112.75 |
22.55 |
135.3 |
|
НСР-4635/15.09.2014; НСР-13233/17.07.2017 |
30.09.2014 |
02.09.2017 |
Заличен |
3172 |
| Somatostatin |
20120385 |
Somatostatin PH&T, Powder and solvent for solution for injection, 3, mg, Pack: 1 флакон + 1 ампула |
PH & T S.p.A., Италия |
Alfa Wassermann S.p.A., Италия |
93.96 |
18.79 |
112.75 |
4% |
3.76 |
97.72 |
19.54 |
117.26 |
16% |
15.03 |
112.75 |
22.55 |
135.3 |
|
НСР-4635/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3172 |
| Somatostatin |
II-0860/15.10.2007 |
Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA, Belgium |
44.53 |
8.91 |
53.44 |
4% |
1.78 |
46.31 |
9.26 |
55.57 |
16% |
7.12 |
53.43 |
10.69 |
64.12 |
|
КЦРР-1205/13.08.2012 г;; НСР-12049/21.03.2017 |
28.12.2012 |
02.05.2017 |
Заличен |
1498 |